Spatiotemporal delivery of multifunctional nanozymes for neuroinflammation alleviation via autophagy modulation in spinal cord injury
Hongyi Jiang, Liting Jiang, Tian Xia, Jiachen Yu, Yitian Bu, Hanting Shen, Liang Zhu, Chihao Lin, Yumeng Wang, Yituo Chen, Rongjie Liu, Junfeng Shi, Jilong Wang, Junjie Deng, Haixiao Liu, Xiaoyun Pan
TL;DR
A new biomimetic nanoplatform delivers nanozymes and siRNA to reduce spinal cord injury inflammation by targeting ROS and autophagy.
Contribution
A spatiotemporal delivery system using a biomimetic nanoplatform that combines nanozymes and siRNA to address ROS and autophagy in spinal cord injury.
Findings
The nanoplatform effectively inhibits neuronal pyroptosis and reprograms M1 macrophages into M2 phenotype.
The system continuously accesses the lesion site from Day 1 to Day 7, targeting the inflammatory microenvironment.
This strategy significantly promotes functional recovery in SCI mice by neutralizing oxidative stress and correcting cellular dysfunction.
Abstract
While nanozymes effectively mitigate neuroinflammation by scavenging reactive oxygen species (ROS), they often fail to address the continuous ROS generation from dysfunctional cells within the spinal cord injury (SCI) microenvironment. Herein, we introduce a “root-cause” therapeutic strategy using a biomimetic nanoplatform (NMm-pPB-siRNATRAF6 that integrates Prussian blue (PB) nanozymes with TRAF6-silencing siRNA to synergistically scavenge ROS and restore cellular homeostasis. Mechanistically, by restoring the impaired autophagic flux, this system effectively inhibits neuronal pyroptosis and reprograms pro-inflammatory M1 macrophages into the reparative M2 phenotype, thereby eradicating ROS at their source. Notably, inspired by the sequential infiltration of immune cells following SCI, we propose the concept of “spatiotemporal delivery”. Achieved through the camouflage of a hybrid…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Immune cells in cancer